It is interesting that while ROSI restores BMAL1 recruitment in a target-specific manner in the tissues examined, prior studies reveal that while ROSI improves hepatic sensitivity, it neither reduces hepatic lipid deposition nor obesity in humans and rodents [45, 46]. This evidence concerns the gene BMAL1 and obesity disorder.